Select Language
COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Depression Drugs Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Drug Class
5.5 Market Breakup by Disorder Type
5.6 Market Breakup by Drug Type
5.7 Market Breakup by Distribution Channel
5.8 Market Breakup by Region
5.9 Market Forecast
6 Market Breakup by Drug Class
6.1 Atypical Antipsychotics
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Selective Serotonin Reuptake Inhibitors (SSRIs)
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Central Nervous System (CNS) Stimulants
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Tricyclic Antidepressants
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Monoamine Oxidase Inhibitors
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Others
6.7.1 Market Trends
6.7.2 Market Forecast
7 Market Breakup by Disorder Type
7.1 Major Depressive Disorder
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Obsessive-Compulsive Disorder
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Generalized Anxiety Disorder
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Panic Disorder
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Drug Type
8.1 Generic Drugs
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Branded Drugs
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by Distribution Channel
9.1 Hospital Pharmacies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Retail Pharmacies
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Online Pharmacies
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Europe
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Asia Pacific
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Middle East and Africa
10.4.1 Market Trends
10.4.2 Market Forecast
10.5 Latin America
10.5.1 Market Trends
10.5.2 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porter’s Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Otsuka Pharmaceutical
15.3.2 Pfizer
15.3.3 Eli Lilly and Company
15.3.4 AstraZeneca
15.3.5 Novartis
15.3.6 Bristol-Myers Squibb
15.3.7 GlaxoSmithKline
15.3.8 Takeda Pharmaceutical Company
15.3.9 Allergan
15.3.10 Johnson & Johnson
15.3.11 Zhejiang NHU Company Ltd
15.3.12 Sebela Pharmaceuticals
List of Figures
Figure 1: Global: Depression Drugs Market: Major Drivers and Challenges
Figure 2: Global: Depression Drugs Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Depression Drugs Market: Breakup by Drug Class (in %), 2020
Figure 4: Global: Depression Drugs Market: Breakup by Disorder Type (in %), 2020
Figure 5: Global: Depression Drugs Market: Breakup by Drug Type (in %), 2020
Figure 6: Global: Depression Drugs Market: Breakup by Distribution Channel (in %), 2020
Figure 7: Global: Depression Drugs Market: Breakup by Region (in %), 2020
Figure 8: Global: Depression Drugs Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 9: Global: Depression Drugs Industry: SWOT Analysis
Figure 10: Global: Depression Drugs Industry: Value Chain Analysis
Figure 11: Global: Depression Drugs Industry: Porter’s Five Forces Analysis
Figure 12: Global: Depression Drugs (Atypical Antipsychotics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: Global: Depression Drugs (Atypical Antipsychotics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: Global: Depression Drugs (Serotonin-Norepinephrine Reuptake Inhibitors) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: Global: Depression Drugs (Serotonin-Norepinephrine Reuptake Inhibitors) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: Global: Depression Drugs (Selective Serotonin Reuptake Inhibitors) Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: Global: Depression Drugs (Selective Serotonin Reuptake Inhibitors) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 18: Global: Depression Drugs (Central Nervous System (CNS) Stimulant) Market: Sales Value (in Million US$), 2015 & 2020
Figure 19: Global: Depression Drugs (Central Nervous System (CNS) Stimulant) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 20: Global: Depression Drugs (Tricyclic Antidepressants) Market: Sales Value (in Million US$), 2015 & 2020
Figure 21: Global: Depression Drugs (Tricyclic Antidepressants) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 22: Global: Depression Drugs (Monoamine Oxidase Inhibitors) Market: Sales Value (in Million US$), 2015 & 2020
Figure 23: Global: Depression Drugs (Monoamine Oxidase Inhibitors) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 24: Global: Depression Drugs (Other Drug Classes) Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: Global: Depression Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 26: Global: Depression Drugs (Major Depressive Disorder) Market: Sales Value (in Million US$), 2015 & 2020
Figure 27: Global: Depression Drugs (Major Depressive Disorder) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 28: Global: Depression Drugs (Obsessive-Compulsive Disorder) Market: Sales Value (in Million US$), 2015 & 2020
Figure 29: Global: Depression Drugs (Obsessive-Compulsive Disorder) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 30: Global: Depression Drugs (Generalized Anxiety Disorder) Market: Sales Value (in Million US$), 2015 & 2020
Figure 31: Global: Depression Drugs (Generalized Anxiety Disorder) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 32: Global: Depression Drugs (Panic Disorder) Market: Sales Value (in Million US$), 2015 & 2020
Figure 33: Global: Depression Drugs (Panic Disorder) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 34: Global: Depression Drugs (Other Disorder Types) Market: Sales Value (in Million US$), 2015 & 2020
Figure 35: Global: Depression Drugs (Other Disorder Types) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 36: Global: Depression Drugs (Generic Drugs) Market: Sales Value (in Million US$), 2015 & 2020
Figure 37: Global: Depression Drugs (Generic Drugs) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 38: Global: Depression Drugs (Branded Drugs) Market: Sales Value (in Million US$), 2015 & 2020
Figure 39: Global: Depression Drugs (Branded Drugs) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 40: Global: Depression Drugs Market: Sales through Hospital Pharmacies (in Million US$), 2015 & 2020
Figure 41: Global: Depression Drugs Market Forecast: Sales through Hospital Pharmacies (in Million US$), 2021-2026
Figure 42: Global: Depression Drugs Market: Sales through Retail Pharmacies (in Million US$), 2015 & 2020
Figure 43: Global: Depression Drugs Market Forecast: Sales through Retail Pharmacies (in Million US$), 2021-2026
Figure 44: Global: Depression Drugs Market: Sales through Online Pharmacies (in Million US$), 2015 & 2020
Figure 45: Global: Depression Drugs Market Forecast: Sales through Online Pharmacies (in Million US$), 2021-2026
Figure 46: Global: Depression Drugs Market: Sales through Other Distribution Channels (in Million US$), 2015 & 2020
Figure 47: Global: Depression Drugs Market Forecast: Sales through Other Distribution Channels (in Million US$), 2021-2026
Figure 48: North America: Depression Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 49: North America: Depression Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 50: Europe: Depression Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 51: Europe: Depression Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 52: Asia Pacific: Depression Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 53: Asia Pacific: Depression Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 54: Middle East and Africa: Depression Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 55: Middle East and Africa: Depression Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 56: Latin America: Depression Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 57: Latin America: Depression Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
List of Tables
Table 1: Global: Depression Drugs Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Depression Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2021-2026
Table 3: Global: Depression Drugs Market Forecast: Breakup by Disorder Type (in Million US$), 2021-2026
Table 4: Global: Depression Drugs Market Forecast: Breakup by Drug Type (in Million US$), 2021-2026
Table 5: Global: Depression Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2021-2026
Table 6: Global: Depression Drugs Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 7: Global: Depression Drugs Market Structure
Table 8: Global: Depression Drugs Market: Key Players
The global depression drugs market was valued at US$ 12.7 Billion in 2020.
Sudden outbreak of the COVID-19 pandemic has negatively impacted the mental health of individuals due to the imposition of lockdown regulations, loss of employments, increased health risks, etc., which are augmenting the demand for depression drugs.
We expect the global depression drugs market to exhibit a CAGR of around 3% during 2021-2026.
The increasing prevalence of social anxiety and depression due to rising work pressure and busy schedules, represents one of the key factors driving the global depression drugs market.
Based on the disorder type, the global depression drugs market has been bifurcated into major depressive disorder, obsessive-compulsive disorder, generalized anxiety disorder, panic disorder, and others. Among these, major depressive disorder holds the majority of the total market share.
Based on the distribution channel, the global depression drugs market can be segmented into retail pharmacies, hospital pharmacies, online pharmacies, and other pharmacies. Currently, retail pharmacies exhibit a clear dominance in the market.
On a regional level, the market has been classified into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America, where North America currently dominates the global market.
Some of the major players in the global depression drugs market include Otsuka Pharmaceutical, Pfizer, Eli Lilly and Company, AstraZeneca, Novartis, Bristol-Myers Squibb, GlaxoSmithKline, Takeda Pharmaceutical Company, Allergan, Johnson & Johnson, Zhejiang NHU Company Ltd, Sebela Pharmaceuticals, etc.
10% Free customization
Purchase Options
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at
sales@imarcgroup.com